Core Viewpoint - A securities fraud class action lawsuit has been filed against Bath & Body Works, Inc. for alleged material misstatements and omissions affecting investors who purchased securities between June 4, 2024, and November 19, 2025 [1][5]. Group 1: Allegations - The lawsuit claims that Bath & Body Works made materially false and misleading statements regarding its business strategy and financial performance during the Class Period [2]. - Specifically, it is alleged that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected net sales growth [2]. - The complaint further asserts that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results, leading to an inability to meet previously issued financial guidance [2]. Group 2: Legal Process - Investors affected by the alleged fraud can seek to be appointed as lead plaintiffs by March 13, 2026, through Kessler Topaz Meltzer & Check, LLP or other counsel [3]. - The lead plaintiff will represent the interests of all class members in directing the litigation and selecting counsel [3]. Group 3: Firm Information - Kessler Topaz Meltzer & Check, LLP is a prominent law firm specializing in securities fraud class actions and represents both individual and institutional investors [5][6]. - The firm has a history of significant recoveries in securities litigation and has received various accolades for its work in this field [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Jayud Global Logistics Ltd. securities between April 21, 2023, and April 30, 2025, of the January 20, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Jayud securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by January 20, 2026, to serve as lead plaintiff, representing other class members [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting that many firms issuing notices may lack the necessary experience [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in securities class action settlements since 2013 [3]. Group 3: Allegations Against Jayud - The lawsuit alleges that during the Class Period, Jayud made materially false and misleading statements, failed to disclose involvement in a fraudulent stock promotion scheme, and omitted critical information regarding share dumping and artificial trading activity [4].

Core Viewpoint - A class action lawsuit has been filed against Smart Digital Group Ltd. (NASDAQ: SDM) for alleged violations of federal securities laws during the Class Period from May 5, 2025, to September 26, 2025 [1][2] Group 1: Allegations and Details - The lawsuit claims that SDM failed to disclose significant information to investors, including involvement in a market manipulation and fraudulent promotion scheme [7] - Allegations include the use of offshore or nominee accounts by insiders to facilitate coordinated share dumping during a price inflation campaign [7] - The company's public statements and risk disclosures did not mention the risks of fraudulent trading or market manipulation that could affect stock prices [7] - As a result, SDM securities faced a unique risk of suspension in trading by the SEC and NASDAQ [7] Group 2: Legal Representation and Participation - Bronstein, Gewirtz & Grossman, LLC represents investors in this class action on a contingency fee basis, meaning they only recover costs if successful [4] - Investors who suffered losses in SDM have until March 16, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud cases [5]

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [5][4]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to between $1.840 billion and $1.854 billion, below analysts' expectations, and projected poor net sales growth of -2% to 2% for 2026. This led to a stock price drop of $35.22 per share, over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 16, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was driving topline growth through category adjacencies [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to lead the case, with claims asserted under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Core Points - The CoreWeave class action lawsuit has been initiated against CoreWeave, Inc. and its executives for alleged violations of the Securities Exchange Act of 1934 during the class period from March 28, 2025, to December 15, 2025 [1][3] - CoreWeave is accused of overstating its ability to meet customer demand and failing to disclose significant risks associated with its reliance on a single third-party data center supplier [3][4] - The lawsuit highlights a significant deal worth up to $11.9 billion with OpenAI announced shortly before CoreWeave's IPO, and a subsequent all-stock acquisition agreement with Core Scientific, which was later terminated due to insufficient shareholder votes [2][4] Allegations and Impact - Allegations include that CoreWeave's executives made misleading statements regarding the company's operational capabilities and the risks posed by its data center supplier, which were likely to negatively impact revenue [3][5] - Following the announcement of lower revenue guidance due to delays from a third-party data center developer, CoreWeave's stock price fell by over 16% [5] - A Wall Street Journal article revealed that delays were more severe than previously acknowledged, leading to an additional 3.4% drop in CoreWeave's stock price [6] Legal Process - Investors who purchased CoreWeave securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to represent the interests of all class members [7][8] - The lead plaintiff can select a law firm to litigate the case, and participation as lead plaintiff is not required to share in any potential recovery [8] About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [9]

Core Points - A securities fraud class action lawsuit has been filed against CoreWeave, Inc. for alleged misstatements and omissions regarding its financial performance and operational risks during the Class Period from March 28, 2025, to December 15, 2025 [1][6] - The lawsuit claims that CoreWeave overstated its ability to meet customer demand and failed to adequately disclose risks associated with reliance on a single third-party data center supplier, which could negatively impact revenue [2] Company Information - CoreWeave, Inc. is publicly traded on NASDAQ under the ticker CRWV and is currently facing legal challenges due to allegations of securities fraud [1][6] - The law firm Kessler Topaz Meltzer & Check, LLP is representing affected investors and has a history of handling significant securities litigation cases [5][7] Legal Process - Investors who suffered losses can seek to be appointed as lead plaintiffs by March 13, 2026, which allows them to represent the class in the lawsuit [3][4] - The firm encourages affected investors to contact them for more information regarding the lawsuit and potential recovery of losses [4][6]

Core Viewpoint - A securities fraud class action lawsuit has been filed against Bath & Body Works, Inc. for alleged material misstatements and omissions during the class period from June 4, 2024, to November 19, 2025, affecting investors who purchased or acquired the company's securities [1][6]. Summary by Relevant Sections Allegations - The complaint claims that Bath & Body Works made materially false and misleading statements and failed to disclose adverse facts about its business and operations [2]. - Specific allegations include the failure of the company's strategy of pursuing "adjacencies, collaborations and promotions" to grow its customer base and net sales [2]. - It is alleged that the company relied on brand collaborations to mask weak financial results and was unlikely to meet its previously issued financial guidance [2]. Legal Process - Investors affected by the alleged fraud can seek to be appointed as lead plaintiffs by March 13, 2026, through Kessler Topaz Meltzer & Check, LLP or other counsel [3]. - The lead plaintiff will represent the class in directing the litigation and selecting counsel, with the ability to share in any recovery not affected by the decision to serve as lead plaintiff [3]. Firm Information - Kessler Topaz Meltzer & Check, LLP is a prominent U.S. law firm specializing in securities-fraud class actions and investor protection, representing both individual and institutional investors [5][7]. - The firm has a history of leading significant recoveries in securities litigation and has received numerous accolades for its work [7].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][4]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].